Sign In
Buy ALBO
$44.15
+0 (+0%)
At Close: May 26, 2023
Albireo Pharma Inc (NASDAQ:ALBO) Expected to Announce Quarterly Sales of $1.49 Million
02:00am, Monday, 13'th Jul 2020
Analysts predict that Albireo Pharma Inc (NASDAQ:ALBO) will report $1.49 million in sales for the current fiscal quarter, according to Zacks Investment Research. Four analysts have made estimates for
Are Options Traders Betting on a Big Move in Albireo (ALBO) Stock?
12:40pm, Friday, 10'th Jul 2020
Investors need to pay close attention to Albireo (ALBO) stock based on the movements in the options market lately.
IM Therapeutics Expands Management Team with Appointments of Tom Shea as CFO/COO and Dr. Sarah Bird as VP, Clinical Development
12:00am, Wednesday, 08'th Jul 2020
ImmunoMolecular Therapeutics, Inc. (“IM Therapeutics”), a leading innovator in the field of precision medicine for autoimmune disease, announced today
Hedge Funds Souring On Albireo Pharma, Inc. (ALBO)
03:02am, Monday, 06'th Jul 2020
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm
Why Albireo Pharma (ALBO) Stock Might be a Great Pick
02:23pm, Wednesday, 01'st Jul 2020
Albireo Pharma (ALBO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Albireo Pharma Inc (NASDAQ:ALBO) Stock Holdings Lessened by UBS Group AG
04:30am, Monday, 22'nd Jun 2020
UBS Group AG reduced its holdings in Albireo Pharma Inc (NASDAQ:ALBO) by 55.1% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 7,365 shares of
Albireo Pharma (NASDAQ:ALBO) Trading 5.8% Higher
02:54am, Sunday, 21'st Jun 2020
Shares of Albireo Pharma Inc (NASDAQ:ALBO) shot up 5.8% during trading on Friday . The stock traded as high as $28.14 and last traded at $27.89, 101,138 shares were traded during trading. An increase
Bank of New York Mellon Corp Has $733,000 Stake in Albireo Pharma Inc (NASDAQ:ALBO)
05:36am, Saturday, 20'th Jun 2020
Bank of New York Mellon Corp boosted its position in shares of Albireo Pharma Inc (NASDAQ:ALBO) by 23.2% in the first quarter, according to the company in its most recent disclosure with the SEC. The
Wall Street Analysts Are Bullish on Top Healthcare Picks - Markets
10:27am, Wednesday, 17'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Xenetic Biosciences
Albireo Pharma (ALBO) Received its Third Buy in a Row - Markets
10:13am, Wednesday, 17'th Jun 2020
After Wedbush and Needham gave Albireo Pharma (NASDAQ: ALBO) a Buy rating last month, the company received another Buy, this
Analysts' Top Healthcare Picks: Albireo Pharma (ALBO), Monopar Therapeutics Inc (MNPR) - Markets
05:58pm, Tuesday, 16'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Albireo Pharma
Albireo to Host Key Opinion Leader Call on Clinical Outcome Assessments
12:00pm, Wednesday, 10'th Jun 2020
Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that it will host a Key Opinion Leader (KOL) call on clinic
Albireo Announces Two Financing Transactions to Extend Cash Runway Into the Beginning of 2022
11:30am, Tuesday, 09'th Jun 2020
Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced it has agreed to terms with Hercules Capital, Inc. (HTGC) on
Albireo to Present at 2020 Jefferies Virtual Healthcare Conference
12:00pm, Tuesday, 26'th May 2020
BOSTON, May 26, 2020 -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that.
The Consensus EPS Estimates For Albireo Pharma, Inc. (NASDAQ:ALBO) Just Fell Dramatically
10:29am, Tuesday, 12'th May 2020
One thing we could say about the analysts on Albireo Pharma, Inc. (NASDAQ:ALBO) - they aren't optimistic, having just...
